Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol

INTRODUCTION: Pre-eclampsia is a common pregnancy condition affecting between 3% and 7% of women. Unfortunately, the exact pathophysiology of the disease is unknown and as such there are no effective treatments that exist notwithstanding prompt delivery of the fetus and culprit placenta. As many cas...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Hobson, Sebastian R, Lim, Rebecca, Gardiner, Elizabeth E, Alers, Nicole O, Wallace, Euan M
التنسيق: Artigo
اللغة:Inglês
منشور في: BMJ Publishing Group 2013
الموضوعات:
Obstetrics and Gynaecology
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3780337/
https://ncbi.nlm.nih.gov/pubmed/24056493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2013-003788
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة